RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RAFA
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Rafarma Pharmaceuticals, Inc. stock price down 3.74% on Thursday
(Updated on May 23, 2024)

Sell candidate since May 21, 2024 PDF

The Rafarma Pharmaceuticals, Inc. stock price fell by -3.74% on the last day (Thursday, 23rd May 2024) from $0.0935 to $0.0900. During the last trading day the stock fluctuated 0% from a day low at $0.0900 to a day high of $0.0900. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -15 thousand shares and in total, 5 thousand shares were bought and sold for approximately $450.00 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -44.52% during the next 3 months and, with a 90% probability hold a price between $0.0417 and $0.0636 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RAFA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Rafarma Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.101 and $0.109. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, May 14, 2024, and so far it has fallen -28.00%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Rafarma Pharmaceuticals, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 4.94%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RAFA) For The Upcoming Trading Day Of Friday 24th

For the upcoming trading day on Friday, 24th we expect Rafarma Pharmaceuticals, Inc. to open at $0.0900, and during the day (based on 14 day Average True Range), to move between $0.0799 and $0.100, which gives a possible trading interval of +/-$0.0101 (+/-11.21%) up or down from last closing price. If Rafarma Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 22.42% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.102, some $0.0120 (13.33%) from the current price of $0.0900, our system finds the risk reward not very attractive.

Is Rafarma Pharmaceuticals, Inc. stock A Buy?

Rafarma Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.032 Strong Sell Candidate Unchanged

Predicted Opening Price for Rafarma Pharmaceuticals, Inc. of Friday, May 24, 2024

Fair opening price May 24, 2024 Current price
$0.0900 ( 0.00000000%) $0.0900

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RAFA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0900 0.00000000 %
R2 0.0900 0.00000000 %
R1 0.0900 0.00000000 %
Current price: 0.0900
Support S1 0.0900 0.00000000 %
S2 0.0900 0.00000000 %
S3 0.0900 0.00000000 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.110 22.22 %
R2 0.103 13.89 %
R1 0.102 13.33 %
Current price 0.0900
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Rafarma Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Rafarma Pharmaceuticals, Inc. is RAFA and it is traded on the PINK (Pink Sheets).

Should I buy or sell Rafarma Pharmaceuticals, Inc. Stock?
Rafarma Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Rafarma Pharmaceuticals, Inc. Stock?
Rafarma Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rafarma Pharmaceuticals, Inc. Stock.

What's the current price of Rafarma Pharmaceuticals, Inc. Stock?
As of the end of day on the May 23, 2024, the price of an Rafarma Pharmaceuticals, Inc. (RAFA) share was $0.0900.

What is the 52-week high and low for Rafarma Pharmaceuticals, Inc. Stock?
The 52-week high for Rafarma Pharmaceuticals, Inc. Stock is $0.427 and the 52-week low is $0.0840.

What is the market capitalization of Rafarma Pharmaceuticals, Inc. Stock?
As of the May 23, 2024, the market capitalization of Rafarma Pharmaceuticals, Inc. is 8.385M.
Click to get the best stock tips daily for free!

About Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological ... RAFA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT